glp 1 palpitations How GLP-1 Medications Affect Your Heart Health Modulation of Cardiac Ventricular Excitability

For MS patients considering GLP-1 therapy, genetic insights help your care team predict whether semaglutide is likely to work well for your individual biology, supporting personalized treatment decisions alongside your neurological clearance

Contact your healthcare provider or seek emergency care if symptoms are concerning

Springer Publishing Company

Once eligibility is confirmed, the healthcare provider will discuss dosage, administration, and the importance of ongoing monitoring to track progress and manage any side effects

The idea was to find substances that might be able to alter human physiology

Exenatide, the first GLP-1RA approved in 2005, demonstrated clinical efficacy but its low homology with human GLP-1 and gastrointestinal side effects restricted widespread use (Muttenthaler et al., 2021)